Literature DB >> 9592569

Korormicin, a novel antibiotic specifically active against marine gram-negative bacteria, produced by a marine bacterium.

K Yoshikawa1, T Takadera, K Adachi, M Nishijima, H Sano.   

Abstract

A novel antibiotic named korormicin was isolated from the marine bacterium, Pseudoalteromonas sp. F-420. This strain was isolated from the surface of a macro alga Halimeda sp. collected from Palau (the Republic of Belau). The planar structure of korormicin was determined by the result of 2D NMR studies and mass spectral data. Korormicin had specific inhibitory activity against marine Gram-negative bacteria, but was inactive against terrestrial microorganisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9592569     DOI: 10.7164/antibiotics.50.949

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

Review 1.  Sodium ion cycle in bacterial pathogens: evidence from cross-genome comparisons.

Authors:  C C Häse; N D Fedorova; M Y Galperin; P A Dibrov
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

2.  The role of glycine residues 140 and 141 of subunit B in the functional ubiquinone binding site of the Na+-pumping NADH:quinone oxidoreductase from Vibrio cholerae.

Authors:  Oscar Juárez; Yashvin Neehaul; Erin Turk; Najat Chahboun; Jessica M DeMicco; Petra Hellwig; Blanca Barquera
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Antibiotic Korormicin A Kills Bacteria by Producing Reactive Oxygen Species.

Authors:  Nicole L Butler; Takeshi Ito; Adam Maynard; Adilson José da Silva; Masatoshi Murai; Tsute Chen; Mattheos A G Koffas; Hideto Miyoshi; Blanca Barquera
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

4.  Identification of the binding sites for ubiquinone and inhibitors in the Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae by photoaffinity labeling.

Authors:  Takeshi Ito; Masatoshi Murai; Satoshi Ninokura; Yuki Kitazumi; Katherine G Mezic; Brady F Cress; Mattheos A G Koffas; Joel E Morgan; Blanca Barquera; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2017-03-15       Impact factor: 5.157

5.  Diversity of antibiotic-active bacteria associated with the brown alga Laminaria saccharina from the Baltic Sea.

Authors:  Jutta Wiese; Vera Thiel; Kerstin Nagel; Tim Staufenberger; Johannes F Imhoff
Journal:  Mar Biotechnol (NY)       Date:  2008-10-15       Impact factor: 3.619

6.  MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30(T), against methicillin-resistant Staphylococcus aureus.

Authors:  Alim Isnansetyo; Yuto Kamei
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  Biofilm development and cell death in the marine bacterium Pseudoalteromonas tunicata.

Authors:  Anne Mai-Prochnow; Flavia Evans; Doralyn Dalisay-Saludes; Sacha Stelzer; Suhelen Egan; Sally James; Jeremy S Webb; Staffan Kjelleberg
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

8.  "Pseudoalteromonas januaria" SUT 11 as the source of rare lipodepsipeptides.

Authors:  Nataliya I Kalinovskaya; Andrey S Dmitrenok; Tatyana A Kuznetsova; Galina M Frolova; Richard Christen; Hartmut Laatsch; Yulia V Alexeeva; Elena P Ivanova
Journal:  Curr Microbiol       Date:  2008-01-08       Impact factor: 2.188

Review 9.  Spotlight on Antimicrobial Metabolites from the Marine Bacteria Pseudoalteromonas: Chemodiversity and Ecological Significance.

Authors:  Clément Offret; Florie Desriac; Patrick Le Chevalier; Jérôme Mounier; Camille Jégou; Yannick Fleury
Journal:  Mar Drugs       Date:  2016-07-08       Impact factor: 5.118

10.  A coralline algal-associated bacterium, pseudoalteromonas strain J010, yields five new korormicins and a bromopyrrole.

Authors:  Jan Tebben; Cherie Motti; Dianne Tapiolas; Peter Thomas-Hall; Tilmann Harder
Journal:  Mar Drugs       Date:  2014-05-13       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.